Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications
The present is a comprehensive review of the immunopathology of Covid-19. The immune
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
A Guillon, PS Hiemstra, M Si-Tahar - Intensive Care Medicine, 2020 - Springer
Although our knowledge of the pulmonary immune response in patients with SARS-CoV-2
infection is still limited, intensivists will be offered to prescribe immunomodulatory …
infection is still limited, intensivists will be offered to prescribe immunomodulatory …
Novel and evolving therapies for COVID-19 related pulmonary complications
PP Mehta, VS Dhapte-Pawar - The American Journal of the Medical …, 2021 - Elsevier
Abstract Coronaviruses disease 2019 (COVID-19) is the most crucial threat, the world has
ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the …
ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the …
Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective
The newfound coronavirus disease 2019 (COVID-19), initiated by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …
Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
A Yarmohammadi, M Yarmohammadi, S Fakhri… - European journal of …, 2021 - Elsevier
As an emerging global health crisis, coronavirus disease 2019 (COVID-19) has been
labeled a worldwide pandemic. Growing evidence is revealing further pathophysiological …
labeled a worldwide pandemic. Growing evidence is revealing further pathophysiological …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Immunity and inflammatory biomarkers in COVID‐19: a systematic review
APD Iwamura, MR Tavares da Silva… - Reviews in Medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
[HTML][HTML] Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
X Li, Y Zhang, L He, J Si, S Qiu, Y He… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in
December 2019, more than 269 million cases and over 5.3 million deaths have been …
December 2019, more than 269 million cases and over 5.3 million deaths have been …
[HTML][HTML] Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
MR Geier, DA Geier - Medical hypotheses, 2020 - Elsevier
A novel virus named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) causes symptoms
that are classified as coronavirus disease (COVID-19). Respiratory conditions are …
that are classified as coronavirus disease (COVID-19). Respiratory conditions are …